3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Hip Fractures
1
Glioma
1
Glioblastoma
1
Fractures, Spontaneous
1
Financial Stress
1
Dysplastic Nevus Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
COVID-19
1
Brain Neoplasms
1
Bone Neoplasms
1
Ataxia Telangiectasia
1
Interventions
Lenalidomide
8
Dexamethasone
7
Bortezomib
6
Cyclophosphamide
4
fludarabine
3
carfilzomib
3
pomalidomide
2
daratumumab
2
belantamab mafodotin
2
Calcium Dobesilate
2
poly ICLC
1
pembrolizumab
1
isatuximab
1
fludarabine phosphate
1
elotuzumab
1
citarinostat
1
Thalidomide
1
Resistance Training
1
Radiotherapy
1
Pharmaceutical Preparations
1
Patient Reported Outcome Measures
1
PVX-410 vaccine
1
Melphalan
1
Exercise
1
Etoposide
1
Equipment and Supplies
1
Doxorubicin
1
Clonal Hematopoiesis
1
Cisplatin
1
Chromatin Immunoprecipitation Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Data Collection
×
90 days
×
Clear all
No trials found.